## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-05-12T13:58:19.695Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Elescan"
developer_entity: "Anescribe, LLC"
bundle_id: "com.elescan.Elescan"
app_store_id: "6743489325"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Freemium"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2026-01-28"
report_date: "2026-05-12"
last_verified: "2026-05-12"
report_version: "1.16"
total_reviews: 5
overall_rating: 4.2
confidence: "low"
confidence_score: 0.35
data_age_days: 0
momentum_velocity: "maintenance"
intelligence_version: 3
competitor_count: 5
tags: ["medical", "freemium", "mobile app", "app review", "app analysis", "healthcare", "providers", "medical"]
canonical_url: "https://marlvel.ai/intel-report/medical/elescan"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# Elescan App Audit

## TL;DR {#tldr}

- **Category**: Medical · Freemium
- **Signal**: Rating 4.2

> **TL;DR:** Elescan is a medical app by Anescribe, LLC, rated 4.2/5 by 5 users, available on iOS.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Elescan is a medical app by Anescribe, LLC.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 4.2/5 (5 reviews) |
| **Category** | Medical |
| **Developer** | Anescribe, LLC |
| **Pricing** | Freemium |
| **Platforms** | iOS |
| **Confidence** | Low (0.35/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** Anescribe, LLC
- **Category:** Medical
- **Target Audience:** Healthcare providers and medical billers who require a secure, mobile-first solution for digitizing and sharing patient documentation.
- **Platforms:** iOS
- **Version Audited:** 1.16
- **Audit Date:** 2026-05-12
- **Signal Count:** 2 reviews analyzed
- **Confidence:** Low (0.35/1.0)
- **App Store ID (iOS):** 6743489325
- **Bundle ID:** com.elescan.Elescan
- **Performance Trend:** Mixed
- **Data Window:** Analysis based on signals collected up to 2026-05-12

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Elescan is a HIPAA-compliant mobile document scanner and cloud storage app designed for healthcare providers and medical billers.
**Why users hire it:** Users hire Elescan to digitize and share sensitive patient data securely without the administrative friction of traditional faxing or enterprise-grade software sales cycles.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] HIPAA-Compliant Cloud Storage:** Automatic secure backup of scanned documents to a HIPAA-compliant cloud environment
  * *User Intent:* Users expect seamless access across multiple devices.
- **[Differentiator] Secure Document Sharing:** Generation of secure access links for document sharing to avoid email attachment size limits
  * *User Intent:* Users prioritize data protection and trust in the platform.
- **[Differentiator] QR Code Login:** Authentication for desktop web console access via QR code scan
  * *User Intent:* Users are motivated by consistent progression and daily incentives.
- **[Standard] Mobile Document Scanner:** Capture of medical documents using device camera with edge detection
- **[Differentiator] Business Associate Agreement (BAA):** Legal documentation required for HIPAA compliance provided to users upon signup
  * *User Intent:* Users seek enhanced value through premium features.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Elescan operates as a specialized medical utility, currently maintaining a 4.2 rating on the iOS platform with a limited review base of 5 total ratings.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Freemium
- **Tiers:** Free tier with limited scans and sharing, Pro Monthly at $11.00/month, Pro Yearly at $109.99/year
- **Analysis:** Freemium model anchored at $11.00/month, gating unlimited storage and web console access to convert professional users.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- BAA-backed compliance provides a legal distribution moat for medical providers
- Typeless login mechanism reduces friction for clinical workflows

**Critical Frictions:**
- Premium tier at $11.00/month above category median
- 5 total ratings indicate low social proof for a security-critical tool

**Growth Levers:**
- Untapped integration with electronic health record (EHR) systems
- Expansion into specialized medical billing workflows

**Market Threats:**
- Established document-management incumbents adding HIPAA-compliance modules
- Low user-count makes the app vulnerable to trust-based churn

<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The intelligence focus has shifted from feature-parity with clinical suites to addressing a critical lack of social proof and re-aligning the competitive set toward specialized utility tools.

**Overall trend**: Mixed
**Compared at**: 2026-05-12

### High-impact changes
- **[Added] Social Proof Weakness** (swot) — Added '5 total ratings indicate low social proof' as a weakness and 'Low user-count makes the app vulnerable to trust-based churn' as a threat.
- **[Shifted] Competitive Landscape Re-alignment** (positioning) — Replaced clinical communication suites (Spruce, Doximity) with specialized utility scanners (Entrupy, AttendStar, DomainDig) in the competitive landscape.

### Medium-impact changes
- **[Shifted] PM Action Item Pivot** (positioning) — Shifted priority from 'Integrate with practice management software' to 'Ship social proof testimonials' to address low rating count.

<!-- section:whats-new -->
## What's New

- **Latest (v1.16, 3 months ago):** Fixed cloud storage upload failures for files with special characters and improved naming validation.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Last major update January 2026.
- Ships stability-focused releases.

> **Cadence:** 1 total versions · 0 majors in last 6 months · 104 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Elescan is an established medical app that is free with in-app purchases.
With a 4.2/5 rating from 5 reviews, it shows polarized user reception.

<!-- speakable-start -->
> **Bottom Line:** Elescan provides a necessary HIPAA-compliant utility for medical providers, but the low social proof threatens long-term adoption, so the PM should prioritize building trust-based testimonials to convert professional users.
<!-- speakable-end -->

**Best for:** Healthcare providers and medical billers who require a secure, mobile-first solution for digitizing and sharing patient documentation.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] [HIGH IMPACT] Ship social proof testimonials because the 5-rating count limits trust for security-critical tools → increase conversion rate — *The 5-rating count is insufficient for a medical-grade security product.* _(trade-off: deprioritize Push the desktop web console feature update to Q3 — trust-building is a higher priority than feature parity.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- Offline scanning mode (available in AttendStar Scanner but missing here)
- Proprietary AI-powered authentication (available in Entrupy but missing here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Stable

The medical utility space is consolidating around established document-management tools, leaving Elescan exposed if it cannot build significant social proof. The current maintenance-mode update cadence suggests a lack of aggressive growth, which will likely lead to stagnation against larger competitors.

- ⚪ The latest release focused on stability, suggesting the team is currently in a maintenance phase rather than aggressive feature expansion.
- 🔴 The low review count limits organic discovery, which will likely stall new-user acquisition until social proof is established.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 4.2/5 |
| Total Reviews | 5 |
| Confidence | Low |
| Pricing Model | Freemium |
| Platforms | iOS |
| Key Features | 5 analyzed |
| Trend | Mixed |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Elescan** (this app) | 4.2/5 | N/A | Anescribe, LLC |
| [DomainDig](https://marlvel.ai/intel-report/utilities/domaindig) | 5.0/5 | N/A | Christian Cleberg |
| [QR Master: Creator & Scanner](https://marlvel.ai/intel-report/shopping/qr-master-creator-scanner) | 5.0/5 | N/A | Robust Research And Development Ltd. |
| [VIN Multi-Tool Decoder Pro](https://marlvel.ai/intel-report/business/vin-multi-tool-decoder-pro) | N/A/5 | N/A | Pierre CARRON DE LA CARRIERE |
| [AttendStar Scanner](https://marlvel.ai/intel-report/utilities/attendstar-scanner) | 4.0/5 | Mixed | AttendStar |
| [Entrupy](https://marlvel.ai/intel-report/business/entrupy) | 4.1/5 | N/A | Entrupy |

## Company Profile
- **Developer:** Anescribe, LLC
- **Website:** [https://elescan.com](https://elescan.com)
- **Social:** [Instagram](https://www.instagram.com/anescribe.llc) · [Facebook](https://www.facebook.com/profile.php?id=61584375911503) · [YouTube](https://www.youtube.com/watch) · [LinkedIn](https://www.linkedin.com/company/108340410)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/elescan/id6743489325?uo=4)
- **Dev Site:** [Official Website](https://elescan.com)
- **Sources:** Developer website content, About us / company information, App store metadata.

## Related Intel Reports
- [*DomainDig*](https://marlvel.ai/intel-report/utilities/domaindig) (Christian Cleberg) — 5.0/5 Rating | N/A Sentiment
- [*QR Master: Creator & Scanner*](https://marlvel.ai/intel-report/shopping/qr-master-creator-scanner) (Robust Research And Development Ltd.) — 5.0/5 Rating | N/A Sentiment
- [*VIN Multi-Tool Decoder Pro*](https://marlvel.ai/intel-report/business/vin-multi-tool-decoder-pro) (Pierre CARRON DE LA CARRIERE) — N/A Rating | N/A Sentiment
- [*AttendStar Scanner*](https://marlvel.ai/intel-report/utilities/attendstar-scanner) (AttendStar) — 4.0/5 Rating | Mixed Sentiment
- [*Entrupy*](https://marlvel.ai/intel-report/business/entrupy) (Entrupy) — 4.1/5 Rating | N/A Sentiment
- [*Beat Social Phobia with AJ*](https://marlvel.ai/intel-report/medical/beat-social-phobia-with-aj) (Universal Relaxation Ltd) — 3.9/5 Rating | Excellent Sentiment
- [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment
- [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment
- [*DeepScribe*](https://marlvel.ai/intel-report/medical/deepscribe) (DeepScribe) — 4.0/5 Rating | N/A Sentiment
- [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.35/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 2
- **Data Sources:** developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/elescan)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.